145 related articles for article (PubMed ID: 16984092)
1. Analgesic effect of corticotropin-releasing hormone: involvement of the hypothalamic-pituitary-adrenocortical axis into its realization.
Bogdanov AI; Yarushkina NI
Bull Exp Biol Med; 2006 Feb; 141(2):184-6. PubMed ID: 16984092
[TBL] [Abstract][Full Text] [Related]
2. [The role of hormones of hypothalamic-pituitary-adrenocortical system in analgesic effect of corticotropin-releasing hormone].
Bogdanov AI; Iarushkina NI
Ross Fiziol Zh Im I M Sechenova; 2006 Feb; 92(2):262-70. PubMed ID: 16739659
[TBL] [Abstract][Full Text] [Related]
3. The role of the hormones of the hypothalamo-hypophyseal-adrenocortical system in the analgesic effect of corticotropin-releasing hormone.
Bogdanov AI; Yarushkina NI
Neurosci Behav Physiol; 2007 May; 37(4):363-7. PubMed ID: 17457531
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of corticotropin-releasing factor-induced analgesic effect in conscious rats].
Iarushkina NI; Bagaeva TR
Ross Fiziol Zh Im I M Sechenova; 2010 Feb; 96(2):128-37. PubMed ID: 20432720
[TBL] [Abstract][Full Text] [Related]
5. Effect of gonadotropin-releasing hormone analogue on thermal nociception in mice.
Bobyntsev II; Sever'yanova LA; Kryukov AA
Bull Exp Biol Med; 2006 Feb; 141(2):193-6. PubMed ID: 16984094
[TBL] [Abstract][Full Text] [Related]
6. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
7. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress.
Jezova D; Ochedalski T; Glickman M; Kiss A; Aguilera G
Neuroscience; 1999; 94(3):797-802. PubMed ID: 10579570
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
[TBL] [Abstract][Full Text] [Related]
9. [The long-term depression of the function of the hypothalamo-hypophyseal-adrenocortical system in rats].
Filaretova LP; Podvigina TT; Bagaeva TR; Filaretov AA
Fiziol Zh Im I M Sechenova; 1995 Jan; 81(1):24-31. PubMed ID: 7489010
[TBL] [Abstract][Full Text] [Related]
10. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
11. Role of the hypothalamic-pituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys.
Lee B; Tiefenbacher S; Platt DM; Spealman RD
Psychopharmacology (Berl); 2003 Jul; 168(1-2):177-183. PubMed ID: 12652344
[TBL] [Abstract][Full Text] [Related]
12. The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1beta administration.
Xu Y; Day TA; Buller KM
Neuroscience; 1999; 94(1):175-83. PubMed ID: 10613507
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
14. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
[TBL] [Abstract][Full Text] [Related]
15. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
Kent P; Anisman H; Merali Z
Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
17. Central corticotropin-releasing factor (CRF) may attenuate somatic pain sensitivity through involvement of glucocorticoids.
Yarushkina NI; Bagaeva TR; Filaretova LP
J Physiol Pharmacol; 2011 Oct; 62(5):541-8. PubMed ID: 22204802
[TBL] [Abstract][Full Text] [Related]
18. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective.
Chrousos GP
Endocrinol Metab Clin North Am; 1992 Dec; 21(4):833-58. PubMed ID: 1486878
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone.
Gavin KM; Shea KL; Gibbons E; Wolfe P; Schwartz RS; Wierman ME; Kohrt WM
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E316-E325. PubMed ID: 29631362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
